TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35589493

Group type: EXPERIMENTAL
Intervention: Blind orotracheal intubation (group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Endoscopic-guided orotracheal intubation (group E)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (B and E)
Number of subjects: 24
Study: 33109390

Group type: EXPERIMENTAL
Intervention: PCV13 2 + 1 (received pneumococcal conjugate vaccine 13 valent at 2, 4 and 12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV13 1 + 1 (received reduced schedule at 3 and 12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 0
Study: 33924514

Group type: EXPERIMENTAL
Intervention: Infant formula enriched with 0.8 g/dL of Orafti®Synergy1
Number of subjects: 160

Group type: COMPARATOR
Intervention: Unsupplemented control formula
Number of subjects: 160
Study: 36239137

Group type: EXPERIMENTAL
Intervention: Behavioural weight management programmes (BWMPs)
Number of subjects: 150000
Study: 33289835

Group type: EXPERIMENTAL
Intervention: MARPE
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyrax
Number of subjects: 60
Study: 32656692

Group type: EXPERIMENTAL
Intervention: Intervention group received a preconception risk assessment, tailored health education, and referral for clinical follow‐up as needed.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group received standard care.
Number of subjects: 40
Study: 35124281

Group type: EXPERIMENTAL
Intervention: Breastfeeding messaging
Number of subjects: 997

Group type: COMPARATOR
Intervention: Safe sleep messaging
Number of subjects: 997
Study: 33576030

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 56

Group type: COMPARATOR
Intervention: 2DRT
Number of subjects: 56
Study: 33221142

Group type: EXPERIMENTAL
Intervention: Community-level alcohol prevention intervention including sobriety checkpoints, saturation patrols, and undercover operations.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 24
Study: 32798488

Group type: EXPERIMENTAL
Intervention: Carfilzomib, dexamethasone, and daratumumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone
Number of subjects: 0
Study: 36510328

Group type: EXPERIMENTAL
Intervention: Deliberate practice intervention (three 30-min sessions with content experts)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Deliberate practice intervention
Number of subjects: 60
Study: 32150484

Group type: EXPERIMENTAL
Intervention: Aster glehni Extract (AGE) 480 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34181721

Group type: EXPERIMENTAL
Intervention: NiTi closed coil springs
Number of subjects: 64

Group type: COMPARATOR
Intervention: Elastomeric chains
Number of subjects: 64
Study: 33208327

Group type: EXPERIMENTAL
Intervention: iThermonitor (WT705)
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Continuous temperature monitoring with iThermonitor
Number of subjects: 526

Group type: COMPARATOR
Intervention: Mercury thermometers (control)
Number of subjects: 526
Study: 36049557

Group type: EXPERIMENTAL
Intervention: Oral everolimus (days 1-3: 7.5 mg qd, days 4-5: 5.0 mg qd)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 35790011

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine solution (TBS) 8 mg (0.4 ml) for cats 1.2 to 3 kg and 20 mg (1 ml) for cats >3 to 7.5 kg, applied topically 1–2 h prior to surgery.
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine solution (TBS)
Number of subjects: 228
Study: 32102803

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) in addition to usual treatment for 16 weeks
Number of subjects: 1

Group type: COMPARATOR
Intervention: Talking control in addition to usual treatment for 16 weeks
Number of subjects: 1
Study: 35193105

Group type: EXPERIMENTAL
Intervention: Beetroot juice (400 mg nitrate in 70 ml volume)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32304248

Group type: EXPERIMENTAL
Intervention: SCTG from the tuberosity area (TG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: SCTG from the lateral palate (CG)
Number of subjects: 29
Study: 35473735

Group type: EXPERIMENTAL
Intervention: Esketamine (0.2 mg/kg body weight)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 564
Study: 33899735

Group type: EXPERIMENTAL
Intervention: Medium high-density lipoprotein (HDL) particles
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Small HDL particles
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Smaller mean HDL particle diameter
Number of subjects: 77
Study: 34979026

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the cervical region (GI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the incisal region (GII)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the total facial surface (GIII)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 35% hydrogen peroxide (H2O2) gel applied to any site
Number of subjects: 30
Study: 34234581

Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy (EGDT) using FloTrac/EV1000 platform
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 86
Study: 33547951

Group type: EXPERIMENTAL
Intervention: Endurance training in hypoxia (FiO2: 14.5%)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Endurance training in normoxia (FiO2: 20.9%)
Number of subjects: 9
Study: 35349416

Group type: EXPERIMENTAL
Intervention: UIPAF patients (38 patients)
Number of subjects: 190

Group type: COMPARATOR
Intervention: IPF patients (152 patients)
Number of subjects: 190
Study: 34498135

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) 3 times per week for 8 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) and Control group (CG)
Number of subjects: 16
Study: 34980256

Group type: EXPERIMENTAL
Intervention: Alternating heat and cold stimulation (HC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heat stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cold stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 20
Study: 32449152

Group type: EXPERIMENTAL
Intervention: Web-based therapist-delivered cognitive behavioral therapy (CBT)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 212
Study: 35641124

Group type: EXPERIMENTAL
Intervention: ABX464 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ABX464 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32704050

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire including the Dutch Musculoskeletal Questionnaire and Modified Nordic Musculoskeletal Questionnaire
Number of subjects: 29547

Group type: EXPERIMENTAL
Intervention: Tertiary hospital workers
Number of subjects: 29547

Group type: EXPERIMENTAL
Intervention: Clinicians
Number of subjects: 29547

Group type: EXPERIMENTAL
Intervention: Log-binomial regression analysis
Number of subjects: 29547
Study: 35914662

Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg subcutaneously every 4 weeks for 24 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34776121

Group type: EXPERIMENTAL
Intervention: Wellness Intervention for Smokers Living with HIV (WISH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care services offered through the National VA Quitline and SmokefreeVET texting program
Number of subjects: 0
Study: 36398042

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate at 40 mg·kg‐1 of actual body weight
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate at 40 mg·kg‐1 of corrected ideal body weight
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no magnesium sulfate)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 75
Study: 33073523

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily for 13 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 26
Study: 34391006

Group type: EXPERIMENTAL
Intervention: 1 treatment course of rTMS
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2 treatment courses of rTMS
Number of subjects: 70
Study: 32730719

Group type: EXPERIMENTAL
Intervention: Robot Group (RG) - accompanied by the robot
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control Group (CG) - without robot accompaniment
Number of subjects: 200
Study: 35428258

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 85
Study: 33989444

Group type: EXPERIMENTAL
Intervention: Telephone group (n=129)
Number of subjects: 255

Group type: COMPARATOR
Intervention: In-person group (n=126)
Number of subjects: 255
Study: 32807294

Group type: EXPERIMENTAL
Intervention: Sleep Intervention Group (SIG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40
Study: 35901477

Group type: EXPERIMENTAL
Intervention: BurstDR stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tonic SCS
Number of subjects: 14
Study: 34612083

Group type: EXPERIMENTAL
Intervention: Two-Thumb Technique
Number of subjects: 78

Group type: COMPARATOR
Intervention: Two-Finger Technique
Number of subjects: 78
Study: 36204903

Group type: EXPERIMENTAL
Intervention: Biodentine 6 mm apical plug
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control (calcium hydroxide)
Number of subjects: 40
Study: 33547980

Group type: EXPERIMENTAL
Intervention: Single 400 μg dose of anti-GnRH vaccine (G1)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Two 400 μg doses of anti-GnRH vaccine (G2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CG) - 1 mL saline 0.9%
Number of subjects: 35
Study: 32844550

Group type: EXPERIMENTAL
Intervention: Butter breakfast
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hazelnut-cocoa spread (HCS) breakfast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fasting and PP TGRL
Number of subjects: 30
Study: 35599990

Group type: EXPERIMENTAL
Intervention: Online group intervention consisting of 12 weekly modules based on cognitive-behavioral methods
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Online group intervention
Number of subjects: 140
Study: 34936268

Group type: EXPERIMENTAL
Intervention: Herb-separated moxibustion on navel combined with Ningmitai capsule
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ningmitai capsule
Number of subjects: 66
Study: 33870812

Group type: EXPERIMENTAL
Intervention: Active-Repeated sprint in hypoxia (A-RSH)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Team Sports-Repeated sprint in hypoxia (T-RSH)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Endurance-Repeated sprint in normoxia (E-RSN)
Number of subjects: 72
Study: 34366282

Group type: EXPERIMENTAL
Intervention: CALM (telehealth intervention)
Number of subjects: 31

Group type: COMPARATOR
Intervention: TAU (treatment-as-usual)
Number of subjects: 31
Study: 35724759

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g intravenously)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 319
Study: 34028005

Group type: EXPERIMENTAL
Intervention: Reading, prep guide, plus group discussion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading plus prep guide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading, prep guide, group discussion, plus clarifying lecture
Number of subjects: 0
Study: 35132096

Group type: EXPERIMENTAL
Intervention: VNS ON
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: VNS OFF
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: taVNS
Number of subjects: 15
Study: 34062224

Group type: EXPERIMENTAL
Intervention: Dual Construct
Number of subjects: 9

Group type: COMPARATOR
Intervention: Two-rod construct
Number of subjects: 9

Group type: COMPARATOR
Intervention: Two-rod with satellite rod
Number of subjects: 9
Study: 36071409

Group type: EXPERIMENTAL
Intervention: P013 (CinnaGen, Iran)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Reference pertuzumab (Perjeta, Roche, Switzerland)
Number of subjects: 214
Study: 33169383

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine without intubation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Anaesthesia providers
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Confidence in skills
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Availability of essential drugs
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Post-operative recovery
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Blood bank availability
Number of subjects: 36
Study: 35126950

Group type: EXPERIMENTAL
Intervention: High-quality care in addition to basic care
Number of subjects: 94

Group type: COMPARATOR
Intervention: Basic care
Number of subjects: 94
Study: 34236131

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) for one hour daily for five weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 116
Study: 32723507

Group type: EXPERIMENTAL
Intervention: Early intervention (supervised exercise and nutritional support)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Delayed intervention (home-based exercise after nutritional support)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Delayed intervention
Number of subjects: 57
Study: 33378835

Group type: EXPERIMENTAL
Intervention: Visual training intervention
Number of subjects: 0
Study: 34750291

Group type: EXPERIMENTAL
Intervention: V114 (15-valent pneumococcal conjugate vaccine)
Number of subjects: 302

Group type: COMPARATOR
Intervention: PCV13 (licensed 13-valent PCV)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: V114
Number of subjects: 302

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 302
Study: 33666305

Group type: EXPERIMENTAL
Intervention: 0.5 mg risperidone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 2 mg risperidone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33157963

Group type: COMPARATOR
Intervention: Propofol (P group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE1 group, volume ratio 1:1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE2 group, volume ratio 2:1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE1 group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE2 group)
Number of subjects: 300
Study: 36397211

Group type: EXPERIMENTAL
Intervention: Mindful eating + TAU
Number of subjects: 76

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 76
Study: 34995176

Group type: EXPERIMENTAL
Intervention: Walking Away Plus (Walking Away with annual group-based support and a mobile health intervention)
Number of subjects: 1366

Group type: EXPERIMENTAL
Intervention: Walking Away (Walking Away with annual group-based support)
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Control (information leaflet)
Number of subjects: 1366
Study: 32414563

Group type: EXPERIMENTAL
Intervention: Educational intervention and follow‐up visits
Number of subjects: 1589

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1589
Study: 36242787

Group type: EXPERIMENTAL
Intervention: Peer-facilitated self-management intervention (PFSMI)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Psychoeducation group (PEG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 180
Study: 36251971

Group type: EXPERIMENTAL
Intervention: Adenosine (120 µg/kg/min over 20 minutes)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 32462791

Group type: COMPARATOR
Intervention: Standard SCS programming
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Differential Target Multiplexed SCS programming
Number of subjects: 25
Study: 33987732

Group type: EXPERIMENTAL
Intervention: aPDT with 0.005% methylene blue and red LED (660 nm, four irradiation points, 90 s per point, power of 400 mW, 36 J per point, radiant exposure of 95 J/cm2, continuous wave)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Tongue scraping
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tongue scraping and aPDT
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 45
Study: 34292199

Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention, performed at least twice a day, four times a week for 8 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention for older adults
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention for middle-aged adults
Number of subjects: 54
Study: 32337738

Group type: EXPERIMENTAL
Intervention: Current use of antipsychotics
Number of subjects: 7084

Group type: EXPERIMENTAL
Intervention: Recent use of antipsychotics
Number of subjects: 7084

Group type: EXPERIMENTAL
Intervention: Recent past use of antipsychotics
Number of subjects: 7084

Group type: EXPERIMENTAL
Intervention: Antipsychotics discontinued >90 days
Number of subjects: 7084

Group type: EXPERIMENTAL
Intervention: Current therapy of antipsychotics at >1 defined daily dose
Number of subjects: 7084
Study: 36181120

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 869
Study: 32076863

Group type: EXPERIMENTAL
Intervention: Gasless endoscopic selective lateral neck dissection via the anterior chest approach (ACA)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional open surgery (OPEN)
Number of subjects: 91
Study: 35797219

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 + gemcitabine
Number of subjects: 336

Group type: COMPARATOR
Intervention: carboplatin
Number of subjects: 336

Group type: COMPARATOR
Intervention: additional anthracycline-containing chemotherapy
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: high sTILs
Number of subjects: 336
Study: 33161116

Group type: COMPARATOR
Intervention: Active control group (Greenlight trial)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Age of TV introduction
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Sociodemographic factors
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Earlier TV watching
Number of subjects: 235
Study: 32390583

Group type: EXPERIMENTAL
Intervention: Video training (demonstration video by Emergency Preparedness Team)
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-person training (standard in-person demonstration by Emergency Preparedness Team member)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Video training
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-person training
Number of subjects: 20
Study: 35014613

Group type: EXPERIMENTAL
Intervention: Maternal oral vitamin D supplementation 1,20,000 IU/month for 12 months
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Maternal oral vitamin D supplementation 12,000 IU/month for 12 months
Number of subjects: 220
Study: 33670285

Group type: EXPERIMENTAL
Intervention: GMO Free labels
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Contains GMOs labels
Number of subjects: 434

Group type: COMPARATOR
Intervention: No GMO labels
Number of subjects: 434
Study: 36435795

Group type: EXPERIMENTAL
Intervention: Moderately restricted carbohydrate (MRC) diet (42–45% carbohydrate, 35–40% fats)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal weight loss (NWL) diet (52–55% carbohydrate, 25–30% fats)
Number of subjects: 70
Study: 32325534

Group type: EXPERIMENTAL
Intervention: Delegation of home visits to health care assistants
Number of subjects: 274

Group type: COMPARATOR
Intervention: Home visits conducted by health care assistants
Number of subjects: 274

Group type: COMPARATOR
Intervention: Self-employment vs. being employed
Number of subjects: 274

Group type: COMPARATOR
Intervention: Single vs. shared practice
Number of subjects: 274

Group type: COMPARATOR
Intervention: Patient numbers per 3 months
Number of subjects: 274

Group type: COMPARATOR
Intervention: Health care assistants' qualifications
Number of subjects: 274

Group type: COMPARATOR
Intervention: Further training for home visits
Number of subjects: 274
Study: 33270064

Group type: EXPERIMENTAL
Intervention: Immediate loading
Number of subjects: 202

Group type: COMPARATOR
Intervention: Delayed loading
Number of subjects: 202
Study: 33975010

Group type: EXPERIMENTAL
Intervention: Dual combination therapy, specifically carbapenem-polymyxin regimen
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Local guidelines for treating CR-GNB
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Access to Infectious Diseases consultation
Number of subjects: 1012
Study: 33853792

Group type: EXPERIMENTAL
Intervention: iDBT-Pain skills training intervention (6 sessions of 60-90 minutes each, delivered via Zoom)
Number of subjects: 3
Study: 36360723

Group type: EXPERIMENTAL
Intervention: Simulated nocturnal train noise (30 events per night, 52 dB(A))
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Simulated nocturnal train noise (60 events per night, 54 dB(A))
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Vitamin C intake after noise exposure
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control pattern (regular background noise)
Number of subjects: 70
Study: 33087159

Group type: EXPERIMENTAL
Intervention: ASP5094 10 mg/kg every 4 weeks for a total of three administrations, alongside concomitant MTX.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo every 4 weeks for a total of three administrations, alongside concomitant MTX.
Number of subjects: 66